MLICM
ATRO icon

Metropolitan Life Insurance Company (MetLife)’s Astronics ATRO Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio ATRO Stock Details ATRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,685
Closed -$26.7K – 205
2024
Q1 		$26.7K Hold
1,685
– – ﹤0.01% 1718
2023
Q4 		$24.5K Hold
1,685
– – ﹤0.01% 1826
2023
Q3 		$22.3K Hold
1,685
– – ﹤0.01% 1839
2023
Q2 		$27.9K Hold
1,685
– – ﹤0.01% 1752
2023
Q1 		$18.8K Buy
1,685
+17
+1% +$190 ﹤0.01% 1916
2022
Q4 		$14.3K Hold
1,668
– – ﹤0.01% 2155
2022
Q3 		$10.9K Hold
1,668
– – ﹤0.01% 2275
2022
Q2 		$14.1K Hold
1,668
– – ﹤0.01% 2212
2022
Q1 		$18K Sell
1,668
-908
-35% -$9.88K ﹤0.01% 2140
2021
Q4 		$25.8K Sell
2,576
-1,844
-42% -$19.4K ﹤0.01% 2746
2021
Q3 		$51.8K Sell
4,420
-4,333
-50% -$55K ﹤0.01% 2756
2021
Q2 		$128K Hold
8,753
– – ﹤0.01% 2461
2021
Q1 		$132K Sell
8,753
-253
-3% -$3.27K ﹤0.01% 2295
2020
Q4 		$99.3K Buy
9,006
+9,005
+900,500% +$73.7K ﹤0.01% 2362
2020
Q3 		$8 Sell
1
-7,855
-100% -$59.8K ﹤0.01% 2555
2020
Q2 		$69.1K Hold
7,856
– – ﹤0.01% 2445
2020
Q1 		$60.1K Buy
7,856
+366
+5% +$6.58K ﹤0.01% 2327
2019
Q4 		$174K Sell
7,490
-2,990
-29% -$73.4K ﹤0.01% 2017
2019
Q3 		$257K Buy
10,480
+1,566
+18% +$42K ﹤0.01% 1710
2019
Q2 		$299K Buy
8,914
+256
+3% +$8.05K 0.01% 1623
2019
Q1 		$236K Hold
8,658
– – ﹤0.01% 1788
2018
Q4 		$220K Sell
8,658
-1,299
-13% -$34.2K ﹤0.01% 1757
2018
Q3 		$314K Hold
9,957
– – 0.01% 1694
2018
Q2 		$260K Sell
9,957
-7,863
-44% -$209K ﹤0.01% 1774
2018
Q1 		$482K Buy
17,820
+8,201
+85% +$245K 0.01% 1303
2017
Q4 		$289K Sell
9,619
-11,156
-54% -$302K ﹤0.01% 1644
2017
Q3 		$448K Hold
20,775
– – ﹤0.01% 1761
2017
Q2 		$459K Buy
20,775
+3,869
+23% +$86.6K ﹤0.01% 1753
2017
Q1 		$389K Sell
16,906
-1,175
-6% -$27.7K ﹤0.01% 1832
2016
Q4 		$443K Sell
18,081
-2,750
-13% -$72.6K ﹤0.01% 1816
2016
Q3 		$591K Sell
20,831
-3,747
-15% -$95.8K ﹤0.01% 1595
2016
Q2 		$515K Hold
24,578
– – ﹤0.01% 1671
2016
Q1 		$591K Hold
24,578
– – ﹤0.01% 1486
2015
Q4 		$630K Sell
24,578
-734
-3% -$17.6K ﹤0.01% 1478
2015
Q3 		$561K Hold
25,312
– – ﹤0.01% 1565
2015
Q2 		$983K Sell
25,312
-1,305
-5% -$51.4K 0.01% 1293
2015
Q1 		$1.07M Hold
26,617
– – 0.01% 1164
2014
Q4 		$807K Hold
26,617
– – 0.01% 1468
2014
Q3 		$695K Sell
26,617
-38
-0.1% -$1.04K 0.01% 1500
2014
Q2 		$687K Hold
26,655
– – ﹤0.01% 1610
2014
Q1 		$772K Hold
26,655
– – 0.01% 1518
2013
Q4 		$621K Sell
26,655
-97
-0.4% -$2.13K ﹤0.01% 1649
2013
Q3 		$486K Hold
26,752
– – ﹤0.01% 1772
2013
Q2 		$400K Buy
+26,752
New +$322K ﹤0.01% 1838

Other funds holding ATRO

NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAM
ACK Asset Management Greenwich, Connecticut $801M AUM 60.42% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s ATRO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Astronics (ATRO) in Q2 2024, closing a stake of 1,685 shares — an estimated $26.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in ATRO in Q2 2013 and held it in 44 quarters. The position peaked at $1.07M in Q1 2015. 132 funds tracked by Wall St. Rank hold ATRO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Astronics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,685 Astronics shares in Q2 2024, an estimated $26.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Astronics in Q2 2013 and held it in 44 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Astronics position peaked at $1.07M in Q1 2015.
  • 132 funds tracked by Wall St. Rank held Astronics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.